Icon Clinical Research New York City, NY - 10017

Icon Clinical Research is categorized under Research and Development Laboratories in New York City, NY .

Icon Clinical Research was established in 0, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Research and Development Laboratories business, which does work in the B2B market, and is classified as a Research and Development Laboratories, under code number 6214930 by the NAICS.

If you are seeking more information, feel free to contact Ray Rivera at the company’s single location by writing to 140 East 45th St Floor 11, New York City, New York NY 10017 or by phoning (212) 682-2666. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Icon Clinical Research
Contact Person: Ray Rivera
Address: 140 East 45th St Floor 11, New York City, New York 10017
Phone Number: (212) 682-2666
Website Address: iconplc.com
Annual Revenue (USD): $1.000.000 to $2.499.999
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Research and Development Laboratories
SIC Code: 8731
NAICS Code: 6214930
Share This Business:

Icon Clinical Research was started in 0 to provide professional Research and Development Laboratories under the SIC code 8731 and NAICS code 6214930. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.

Feel free to contact Ray Rivera for inquiries that concern Icon Clinical Research by calling the company number (212) 682-2666, as your correspondence is most welcome. Additionally, the physical location of the single location of Icon Clinical Research can be found at the coordinates 40.753163,-73.974309 as well as the street address 140 East 45th St Floor 11 in New York City, New York 10017.

For its online presence, you may visit Icon Clinical Research’s website at iconplc.com and engage with its social media outlets through on Twitter and on Facebook.